US Patent Issued to SomaLogic Operating on Dec. 30 for "Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof" (Colorado Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,510,550, issued on Dec. 30, was assigned to SomaLogic Operating Co. Inc. (Boulder, Colo.).

"Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof" was invented by Stuart Field (Boulder, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD), and more specifically one or more of the following associated conditions of steatosis, lobular inflammation, hepatocyte ballooning and fibrosis, are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis a...